Skip to main content
. 2018 Jan 15;10(3):283–296. doi: 10.4155/fmc-2017-0159

Figure 3. . Hemolytic activity and cytotoxicity of OZE-I, -II and OZE-III.

Figure 3. 

(A) Human erythrocytes were treated with serial dilutions of Triton X-100 (0.002–001%) or compounds (0.125–164 μg/ml). (B) Cytotoxicity of compounds was evaluated using HepG2 cells. The viability of HepG2 cells was measured after treatment with serially diluted concentrations (0.125–164 μg/ml) of each compound.